Venture Capital Investors

Negev Capital

Negev Capital makes VC investments in good companies that are leveraging tech to solve important problems.

Venture Investor Overview

Contact Information

Background Information

Overview

Negev Capital is a psychedelic medical intervention investment fund with assets of USD$20+ million. We invest in drug discovery, with a focus on preclinical and/or Phase 1 stages of development. We aim to support those early stage companies in need of capital that promote the thoughtful, responsible, medical use of psychedelic medication forpsychiatric disorders, and who have excellent management and science teams, and solid IP.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

12/16/2022

Transaction History

Our records indicate that Negev Capital invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Investor Contacts

Title

Name

Email & Social

Partner

Ken Belotsky

        

Partner

Stuart Seidman

        

Partner

Vadim Uzberg

        

Funds

No fund closings have been recorded for this company.

Portfolio Companies

Negev Capital has invested in the companies below, according to our database records. If we are missing a portfolio company, please let us know.

Browse more venture capital investors:

Nefco | Nekkanti Sea Foods

Share this article

About Our Venture Capital Investor Database

This VC firm profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary